Functional and Celluar Assessment of Limited Remyelination in the Cuprizone Model
Norah Hibbits
Abstract
Norah Hibbits
Abstract
Abstract : The promotion of remyelination after chronic or prolonged episodes of demyelination is an important therapeutic goal for demyelinating diseases. The leading cause of demyelination in humans is multiple sclerosis (MS). This thesis work focused on a mouse model of MS to examine cellular and molecular mechanisms that may cause limited remyelination after chronic demyelination. Cuprizone, a neurotoxicant, was used to induce experimental demyelination. This model mimics the effects of acute and chronic time courses of demyelinating disease progression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract : The promotion of remyelination after chronic or prolonged episodes of demyelination is an important therapeutic goal for demyelinating diseases. The leading cause of demyelination in humans is multiple sclerosis (MS). This thesis work focused on a mouse model of MS to examine cellular and molecular mechanisms that may cause limited remyelination after chronic demyelination. Cuprizone, a neurotoxicant, was used to induce experimental demyelination. This model mimics the effects of acute and chronic time courses of demyelinating disease progression.
Key concepts: Remyelination, Multiple sclerosis, Demyelinating disease, Medicine, Neuroscience, Disease, Immunology, Myelin